PRODUCT
Identify and recruit patients as clinical trial participants; create virtual control groups to replace or supplement trial controls
Learn More
Accelerate rare disease trials with our longitudinal, real-world data—from patient recruitment to external control arms and regulatory support.
Patient Access
Identify & recruit patients (including those not yet diagnosed through customized rare-disease detection algorithms)
Validation
‘Synthetic’ or ‘Pragmatic External’ Control Arms, as allowed under the 21st Century Cures Act
Regulatory Support
Regulatory filings support, address of Adverse Events, and other retrospective RWE as needed to explain and put in a disease-context any specific trial results
Clinical Trial Design
Clinical Trial Design through analysis of large patient populations for relevant characteristics
One Of A Kind Data
TriAxia is the only source in the world for this combination and scale of longitudinal clinical data for Pulmonary Hypertension and rare Interstitial Lung Diseases
PRODUCTS
Powering the discovery, development, and deployment of new rare disease therapies
Real World Evidence + Advanced Analytics
Bespoke dataframes with HEOR services including advanced traditional and AI-enabled analytics
Learn More
Bioinformatics and Genomics
Generate and test hypotheses for genes and pathways as potential drug targets or biomarkers, explore patient sub-segmentation, and more
Learn More